Adjust the slider to show how you'd split your country's finite resources between the military (weapons and armed forces) and clinical trials to cure and treat disease.
Current clinical trial costs are 82x times higher than pragmatic trial alternatives.
Traditional clinical trials cost $41K per participant, exceeding median annual income in many countries.
The average cost to develop a new drug is $2.6B, reflected in pharmaceutical pricing.
Regulatory delays contribute to an estimated 21,000-120,000 preventable deaths per decade.
Current trial eligibility criteria exclude 86.1% of patients with the condition being studied.
95% of known diseases lack FDA-approved treatments, with research concentrated on the remaining 5%.
The average time from discovery to widespread clinical adoption is 17 years.
An estimated 45.1B potential treatment combinations remain untested with current methodologies.
Approximately 2.4B people worldwide suffer from diseases with inadequate treatment options.
No major disease has been cured in over 44 years, highlighting the need for new research paradigms.
HUMANITY SPENDS
THAN CURING ALL DISEASES COMBINED
That tiny line on the left? That's ALL of modern medicine.
You cannot have "diminishing returns" when you haven't even started.
The 9.5M figure above only counts single drugs against diseases. Modern medicine increasingly uses combination therapies (standard in oncology, HIV, cardiology).
Note: We use the conservative 9.5M figure in our main calculations because single-drug trials are more straightforward. But the combination therapy space shows the true scale of unexplored medicine.
Clinical trials are how we discover which treatments work for which diseases. At current trial capacity, we find first effective treatments for only ~15 diseases per year.
Pragmatic trials cost ~44× less than traditional trials. The treaty would fund 12× more trials = ~180 first treatments per year.
Critics argue: "Just funding more trials won't proportionally increase discoveries - we've picked the low-hanging fruit."
This is wrong for six reasons:
Diminishing returns apply to repeated attempts at the same problem. We're proposing to attempt problems we've never tried.
The treatments exist. The safe compounds exist. The patients are waiting.
The only missing ingredient is trial capacity. That's a logistics problem, not a scientific frontier.
See the ROI →CONSUMER REPORTS FOR DRUGS
A decentralized framework for drug assessment integrated into standard healthcare could both radically improve safety and allow patients to effortlessly participate in pragmatic decentralized clinical trials.
Find drugs, supplements, diets, devices - everything ranked by real-world effectiveness
Not marketing claims. Actual data from millions of real patients showing what works
One-click enrollment in pragmatic trials. Get paid to test treatments while helping humanity
Transparent rankings based on effectiveness, side effects, and cost-effectiveness
Enter your condition. Get a ranked list of every treatment ever tested.
See side-by-side outcomes: LDL reduction, survival rates, quality of life - actual numbers, not promises.
Choose based on data, not marketing budgets. Your body, your choice, informed by millions of data points.
Source information not available.
When you stop making people fill out paperwork and start letting them not die, something magical happens:
$637 returned for every $1 invested
Not a typo. Not a fever dream. Actual math.
This beats humanity's previous greatest hits in the "not dying" genre:
WHERE THE VALUE COMES FROM:
Value comes from faster drug approvals (17 years → 2 years), better treatment matching through real-world data, and addressing neglected diseases that companies ignore.
A 84.8M:1 Return on Investment
A $1.0B campaign yields $84.8 Quadrillion in health value.
Where The Value Comes From:
Math says this is the best possible use of a billion dollars.
Math is rarely wrong about money. People are frequently wrong about money.
Charts, breakdowns, and all the nerdy details
Adjust the slider to show how you'd split your country's finite resources between the military (weapons and armed forces) and clinical trials to cure and treat disease.
$27.2B/year scales trial capacity 12X, achieving 246 years of progress in 20
By eliminating the 8.2-year regulatory delay through pragmatic trials integrated into standard care
Highest ROI Action in History
In 30 seconds, you can save more lives than most people save in a lifetime.